New genetic test can improve ovarian cancer treatment


A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors, a treatment option.

Brain-computer-leg interface restores motion after stroke

Previous article

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations